Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds FDA Grants Approval Of Tzield To Provention Bio

FDA Grants Approval Of Tzield To Provention Bio

https://www.fda.gov/news-events/press-announcements/fda-approves-first-drug-can-delay-onset-type-1-diabetes

byBill Haddad

November 17, 2022

1 minute read

https://www.fda.gov/news-events/press-announcements/fda-approves-first-drug-can-delay-onset-type-1-diabetes

Here’s Why VEON Shares Are Up Over 11% Today

By Anusuya Lahiri

November 2, 12:26 PM

Converged connectivity and online services provider VEON Ltd (NASDAQ:VEON) conducted a competitive sales process concerning its Russian operations. VEON’s management weighed…

VEON

Media
News

Elon Musk Asked A Top Tesla Executive To Forfeit Unvested Equity Awards And He Promptly Quit: Report

By Shanthi Rexaline

November 13, 10:32 AM

Multiple reports and testimonies have painted Tesla, Inc.

MBGAF

Plp Names J. Ryan Ruhlman President Of The Company

By Happy Mohamed

May 18, 10:32 AM

The Board of Directors of Preformed Line Products Company (NASDAQ:PLPC) is pleased to announce that it has appointed Mr. J. Ryan Ruhlman, age 40, as President of the Company. He takes over this role

PLPC

GigaMedia Q2 EPS $(0.10) Down From $(0.08) YoY

By Benzinga Newsdesk

July 29, 9:02 AM

GigaMedia (NASDAQ:GIGM) reported quarterly losses of $(0.10) per share. This is a 25 percent decrease over losses of $(0.08) per share from the same period last year.

GIGM

FDA Grants Approval Of Tzield To Provention Bio

Related Posts

Here’s Why VEON Shares Are Up Over 11% Today

Elon Musk Asked A Top Tesla Executive To Forfeit Unvested Equity Awards And He Promptly Quit: Report

Plp Names J. Ryan Ruhlman President Of The Company

GigaMedia Q2 EPS $(0.10) Down From $(0.08) YoY